Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Letermovir”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Large-scale testing (Phase 3)Study completedNCT03443869
What this trial is testing

Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK-8228-002)

Who this might be right for
CMV Disease
Merck Sharp & Dohme LLC 601
Large-scale testing (Phase 3)Study completedNCT02137772
What this trial is testing

Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)

Who this might be right for
Prevention of CMV Infection or Disease
Merck Sharp & Dohme LLC 570
Large-scale testing (Phase 3)Active Not RecruitingNCT06449586
What this trial is testing

CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT

Who this might be right for
Hematologic Malignancy
Ruijin Hospital 250
Not applicableStudy completedNCT05789615
What this trial is testing

Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China

Who this might be right for
CMV InfectionHematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University 200
Post-approval studies (Phase 4)Study completedNCT04904614
What this trial is testing

Letermovir Use in Heart Transplant Recipients

Who this might be right for
Cytomegalovirus DiseaseCytomegalovirus InfectionsHeart Transplant Infection+2 more
Tufts Medical Center 32
Testing effectiveness (Phase 2)Looking for participantsNCT06920251
What this trial is testing

Phase II Trials of Letermovir Prophylaxis in Patients With RRMM Undergoing Elranatamab Therapy

Who this might be right for
Relapsed Refractory Multiple Myeloma (RRMM)
Seoul National University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT03940586
What this trial is testing

Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030)

Who this might be right for
Cytomegalovirus (CMV) Infection
Merck Sharp & Dohme LLC 65
Not applicableLooking for participantsNCT06812598
What this trial is testing

Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT

Who this might be right for
Cytomegalovirus InfectionsCMV
The First Affiliated Hospital of Soochow University 330
Early research (Phase 1)Looking for participantsNCT07199465
What this trial is testing

A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)

Who this might be right for
Cytomegalovirus Prophylaxis
Merck Sharp & Dohme LLC 40
Not applicableUnknownNCT06306989
What this trial is testing

Observational Clinical Study of Letermovir for Preventing CMV Infection After Allo-HSCT

Who this might be right for
Letemovir for the Prevention of CMV Infection After Allo-HSCT
Cao Weijie 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06057194
What this trial is testing

Efficacy of Letermovir in Preventing Cytomegalovirus (CMV) Infection in Lung Transplant Recipients vs. Valganciclovir.

Who this might be right for
Infections, Cytomegalovirus
Maimónides Biomedical Research Institute of Córdoba 90
Testing effectiveness (Phase 2)Study completedNCT04017962
What this trial is testing

The Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection

Who this might be right for
CMVCMV InfectionHematopoietic Cell Transplant
Memorial Sloan Kettering Cancer Center 102
Early research (Phase 1)Study completedNCT06118515
What this trial is testing

A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus

Who this might be right for
Congenital Cytomegalovirus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 3
Post-approval studies (Phase 4)Not Yet RecruitingNCT07706166
What this trial is testing

Letermovir for R+ Study

Who this might be right for
Kidney TransplantLiver Transplant
University of Wisconsin, Madison 146
Large-scale testing (Phase 3)Looking for participantsNCT05446571
What this trial is testing

Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir

Who this might be right for
Pregnant WomenCMV Infected Fetuses
Assistance Publique - Hôpitaux de Paris 46
Large-scale testing (Phase 3)Study completedNCT04129398
What this trial is testing

MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese Kidney Transplant Recipients (MK-8228-042)

Who this might be right for
Cytomegalovirus InfectionCytomegalovirus Disease
Merck Sharp & Dohme LLC 22
Not applicableNot Yet RecruitingNCT06814301
What this trial is testing

Impact of CMV-Specific Immune Reconstitution at the End of Letermovir Prophylaxis on the Development of Late Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Recipients (INMUNOEND)

Who this might be right for
Cytomegalovirus Cell Mediated ImmunityStem Cell Transplantation, Hematopoietic
Maimónides Biomedical Research Institute of Córdoba 123
Post-approval studies (Phase 4)Not Yet RecruitingNCT07571135
What this trial is testing

Letermovir vs Valganciclovir in CMV R+ Kidney Transplant

Who this might be right for
CMV InfectionCMVCMV Viremia+1 more
Elisabeth Kincaide 300
Post-approval studies (Phase 4)UnknownNCT05914701
What this trial is testing

Secondary Prophylaxis of CMV Infection Using Letermovir After HID-HSCT

Who this might be right for
To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation
Institute of Hematology & Blood Diseases Hospital, China 31
Not applicableStudy completedNCT05362916
What this trial is testing

Letermovir in ART-treated HIV-infected Persons

Who this might be right for
People Living With HIV
Jean-Pierre Routy 33
Next Page